{"id":3859,"date":"2018-09-24T06:42:35","date_gmt":"2018-09-24T06:42:35","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/"},"modified":"2018-09-24T06:42:35","modified_gmt":"2018-09-24T06:42:35","slug":"nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/","title":{"rendered":"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span>Nanexa har knutit till sig professor Axel Glasmacher som medicinsk r\u00e5dgivare till bolagets produktprojekt inom cancerindikationerna MDS (severe myelodysplastic syndrome) och AML (acute myeloid leukemia).\u00a0<\/span><\/p>\n<p><span>Professor Axel Glasmacher, MD, var tills nyligen Senior Vice President och chef f\u00f6r Global Clinical Research and Development inom hematologi och onkologi p\u00e5 Celgene d\u00e4r han arbetat i olika globala positioner i mer \u00e4n tio \u00e5r. Innan dess arbetade professor Axel Glasmacher inom hematologi\/onkologi-omr\u00e5det p\u00e5 universitetssjukhuset i Bonn.<\/span><\/p>\n<p><span><em>Nanexas VD David Westberg kommenterar:\u00a0<\/em><\/span><\/p>\n<p><span><em>Det \u00e4r av st\u00f6rsta vikt att vi kan knyta till oss personer med v\u00e4rldsledande spetskompetens inom de indikationsomr\u00e5den vi arbetar med. Det \u00e4r d\u00e4rf\u00f6r v\u00e4ldigt gl\u00e4djande att professsor Glasmacher som under en l\u00e5ng tid arbetat med l\u00e4kemedelsutveckling inom MDS\/AML-indikationerna valt att arbeta med oss i v\u00e5rt produktprojekt. Det ger oss v\u00e4rdefull information under utvecklingsfasen och st\u00e4rker v\u00e5r position kommersiellt fram\u00f6ver.<\/em><\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<\/span><\/p>\n<p><span>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/span><\/p>\n<p><span>?Telefon: 0709 &#8211; 42 83 03?<\/span><\/p>\n<p><span>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\" rel=\"nofollow\">david.westberg@nanexa.se<\/a><\/span><\/p>\n<p><span>www.nanexa.com<\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00aesom \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00aehar Nanexa samarbetsavtal med bland andra AstraZeneca.<\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"http:\/\/mb.cision.com\/Main\/12591\/2625764\/914430.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>Nanexa har knutit till sig professor Axel Glasmacher som medicinsk r\u00e5dgivare till bolagets produktprojekt inom cancerindikationerna MDS (severe myelodysplastic syndrome) och AML (acute myeloid leukemia).\u00a0<\/p>\n<p>Professor Axel Glasmacher,<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3859","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa har knutit till sig professor Axel Glasmacher som medicinsk r\u00e5dgivare till bolagets produktprojekt inom cancerindikationerna MDS (severe myelodysplastic syndrome) och AML (acute myeloid leukemia).\u00a0 Professor Axel Glasmacher,L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\\\/\",\"name\":\"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-09-24T06:42:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB","og_description":"Nanexa har knutit till sig professor Axel Glasmacher som medicinsk r\u00e5dgivare till bolagets produktprojekt inom cancerindikationerna MDS (severe myelodysplastic syndrome) och AML (acute myeloid leukemia).\u00a0 Professor Axel Glasmacher,L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/","name":"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-09-24T06:42:35+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-forstarker-teamet-med-professor-axel-glasmacher-som-medicinsk-radgivare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa f\u00f6rst\u00e4rker teamet med professor Axel Glasmacher som medicinsk r\u00e5dgivare"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}